Tillotts Pharma AG

Tillotts Pharma AG, part of the Japanese Zeria Group, is a fast-growing specialty pharma company with close to 400 employees in Switzerland and abroad. Tillotts is dedicated to the development, acquisition and commercialization of innovative pharmaceutical products for the digestive system. Tillotts successfully markets its own products for the treatment of IBD and Clostridioides difficile infection (CDI) as well as in-licensed products in around 65 countries through its affiliates within Europe and a network of partners throughout the world.

Tillotts is dedicated to partnering with HCPs to provide support and educational programmes that can help HCPs improve outcomes for people with GI-diseases. GI Health is our PassionTM. All trademarks used or mentioned here are protected by law.

For more information, visit www.tillotts.com

© Copyright. All rights reserved. See our community guidelines: http://bit.ly/2skHg2v